Makers Labs.

Market Cap: Micro Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE987A01010
NSEID:
BSEID: 506919
View on BSE

INR

153.00

5.3 (3.59%)

BSENSE

Mar 13

BSE+NSE Vol: 3.58 k

{
  "main_header": {
    "sid": 878419,
    "name": "Makers Labs.",
    "stock_name": "Makers Labs.",
    "full_name": "Makers Laboratories Ltd",
    "name_url": "stocks-analysis/makers-labs",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "153.00",
    "chg": 5.3,
    "chgp": "3.59%",
    "dir": 1,
    "prev_price": "147.70",
    "mcapval": "87.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 506919,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE987A01010",
    "curr_date": "Mar 13",
    "curr_time": "",
    "bse_nse_vol": "3.58 k",
    "exc_status": "Active",
    "traded_date": "Mar 13, 2026",
    "traded_date_str": "2026 03 13",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/makers-labs-878419-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Makers Laboratories Ltd Upgraded to Sell: A Detailed Analysis of the Rating Change",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/makers-laboratories-ltd-upgraded-to-sell-a-detailed-analysis-of-the-rating-change-3884504",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/MakersLaborator_mojoScore_3884504.png",
        "date": "2026-03-11 08:09:12",
        "description": "Makers Laboratories Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 10 Mar 2026, driven primarily by a shift in technical indicators despite ongoing fundamental challenges. The company’s stock price has gained nearly 5% in a single day, reflecting renewed market interest amid mixed signals from financial performance and valuation metrics."
      },
      {
        "title": "Makers Laboratories Ltd Downgraded to Strong Sell Amid Mixed Technicals and Weak Fundamentals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/makers-laboratories-ltd-downgraded-to-strong-sell-amid-mixed-technicals-and-weak-fundamentals-3865921",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/MakersLaborator_mojoScore_3865921.png",
        "date": "2026-03-03 08:24:00",
        "description": "Makers Laboratories Ltd has been downgraded from a Sell to a Strong Sell rating as of 2 March 2026, reflecting deteriorating technical indicators and persistent fundamental weaknesses. Despite some positive quarterly financial results, the company’s valuation, long-term financial trends, and technical signals have collectively triggered a reassessment of its investment appeal."
      },
      {
        "title": "Makers Laboratories Ltd Upgraded to Sell on Technical Improvements and Mixed Fundamentals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/makers-laboratories-ltd-upgraded-to-sell-on-technical-improvements-and-mixed-fundamentals-3857404",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/MakersLaborator_mojoScore_3857404.png",
        "date": "2026-02-26 08:06:20",
        "description": "Makers Laboratories Ltd has seen its investment rating upgraded from Strong Sell to Sell, driven primarily by improved technical indicators and recent positive quarterly financial results. However, the company continues to face challenges in valuation and long-term fundamental strength, prompting a cautious stance despite short-term momentum gains."
      },
      {
        "title": "Makers Laboratories Ltd Downgraded to Strong Sell Amid Weak Fundamentals and Bearish Technicals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/makers-laboratories-ltd-downgraded-to-strong-sell-amid-weak-fundamentals-and-bearish-technicals-3845188",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/MakersLaborator_mojoScore_3845188.png",
        "date": "2026-02-18 08:11:39",
        "description": "Makers Laboratories Ltd has been downgraded from a Sell to a Strong Sell rating as of 17 Feb 2026, reflecting a deterioration in its technical outlook, valuation metrics, and long-term financial trends. Despite some positive quarterly results, the company’s overall fundamentals and market performance have raised concerns, prompting a reassessment of its investment appeal within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Makers Laboratories Gains 5.85%: 3 Key Factors Driving the Weekly Move",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/makers-laboratories-gains-585-3-key-factors-driving-the-weekly-move-3839621",
        "imagepath": "",
        "date": "2026-02-14 14:04:33",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>09 Feb:</strong> Stock surges 6.58% on strong volume</p>\n                    <p><strong>10 Feb:</strong> Q3 FY26 results reveal profit surge</p>\n                    <p><strong>11 Feb:</strong> Mixed annual performance reported; stock dips 5.93%</p>\n                    <p><strong>12 Feb:</strong> Technical and financial trends improve; stock rallies 7.60%</p>\n                    <p><strong>13 Feb:</strong> MarketsMOJO upgrades rating to Sell; stock closes at ₹136.70</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.129.15</div></div>\n                    <di..."
      },
      {
        "title": "Makers Laboratories Ltd Upgraded to Sell on Improving Financial and Technical Trends",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/makers-laboratories-ltd-upgraded-to-sell-on-improving-financial-and-technical-trends-3836712",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/MakersLaborator_mojoScore_3836712.png",
        "date": "2026-02-13 08:11:15",
        "description": "Makers Laboratories Ltd has seen its investment rating upgraded from Strong Sell to Sell following a marked improvement in its financial performance and technical indicators. Despite lingering concerns over long-term fundamentals and valuation, the recent quarterly results and market momentum have prompted a reassessment of the company’s outlook."
      },
      {
        "title": "Makers Laboratories Ltd Reports Strong Quarterly Upswing Amid Mixed Annual Performance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/makers-laboratories-ltd-reports-strong-quarterly-upswing-amid-mixed-annual-performance-3832193",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/MakersLaborator_fintrenddot_3832193.png",
        "date": "2026-02-11 08:00:39",
        "description": "Makers Laboratories Ltd has demonstrated a notable turnaround in its quarterly financial performance for December 2025, registering its highest-ever net sales and profitability metrics despite a challenging nine-month period marked by significant profit contraction. The company’s recent financial trend has shifted from flat to positive, signalling potential recovery in the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Are Makers Laboratories Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-makers-laboratories-ltd-latest-results-good-or-bad-3831502",
        "imagepath": "",
        "date": "2026-02-10 19:27:25",
        "description": "Makers Laboratories Ltd's latest financial results for Q3 FY26 present a mixed picture of operational performance. The company reported consolidated net sales of ₹35.67 crores, reflecting a year-on-year growth of 28.82%, which marks the highest quarterly revenue in at least seven quarters. This growth indicates a positive trend in demand for the company's products. Additionally, the operating margin, excluding other income, improved to 11.66%, showcasing operational leverage and cost management.\n\nHowever, the consolidated net profit for the quarter was ₹0.94 crores, which, while positive compared to the previous quarter's loss, represents a significant decline in profitability when viewed over a nine-month period, with profits plummeting 84.86% year-on-year. This raises concerns about the sustainability of the recent quarterly improvement. \n\nOn a standalone basis, the company reported a net profit of ₹2.27 ..."
      },
      {
        "title": "Makers Laboratories Q3 FY26: Profit Surge Masks Deeper Structural Concerns",
        "link": "https://www.marketsmojo.com/news/result-analysis/makers-laboratories-q3-fy26-profit-surge-masks-deeper-structural-concerns-3831368",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/MakersLaborator_quaterlyResult_3831368.png",
        "date": "2026-02-10 15:46:52",
        "description": "Makers Laboratories Ltd., a micro-cap pharmaceutical manufacturer with a market capitalisation of ₹85.56 crores, reported a consolidated net profit of ₹0.94 crores for Q3 FY26 (October-December 2025), marking a dramatic turnaround from a loss of ₹0.30 crores in the year-ago quarter. However, the seemingly impressive quarterly performance conceals troubling underlying trends that raise serious questions about the sustainability of this recovery."
      }
    ],
    "total": 110,
    "sid": "878419",
    "stock_news_url": "https://www.marketsmojo.com/news/makers-laboratories-878419"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "11-Feb-2026",
      "details": "Copy of Newspaper Publication",
      "source": "BSE"
    },
    {
      "caption": "Standalone And Consolidated Financial Results For 3Rd Quarter And Nine Months Ended 31.12.2025",
      "datetime": "10-Feb-2026",
      "details": "Standalone and Consolidated Financial Results for 3rd quarter and nine months ended 31.12.2025",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Standalone And Consolidated Financial Results For 3Rd Quarter And Nine Months Ended 31.12.2025",
      "datetime": "10-Feb-2026",
      "details": "Standalone and Consolidated Financial Results for 3rd quarter and nine months ended 31.12.2025",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Makers Laboratories Ltd has declared <strong>10%</strong> dividend, ex-date: 01 Aug 19",
          "dt": "2019-08-01",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Makers Laboratories Ltd has announced <strong>1:5</strong> rights issue, ex-date: 30 Mar 22",
          "dt": "2022-03-30",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

Makers Laboratories Ltd Upgraded to Sell: A Detailed Analysis of the Rating Change

2026-03-11 08:09:12

Makers Laboratories Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 10 Mar 2026, driven primarily by a shift in technical indicators despite ongoing fundamental challenges. The company’s stock price has gained nearly 5% in a single day, reflecting renewed market interest amid mixed signals from financial performance and valuation metrics.

Read full news article

Makers Laboratories Ltd Downgraded to Strong Sell Amid Mixed Technicals and Weak Fundamentals

2026-03-03 08:24:00

Makers Laboratories Ltd has been downgraded from a Sell to a Strong Sell rating as of 2 March 2026, reflecting deteriorating technical indicators and persistent fundamental weaknesses. Despite some positive quarterly financial results, the company’s valuation, long-term financial trends, and technical signals have collectively triggered a reassessment of its investment appeal.

Read full news article

Makers Laboratories Ltd Upgraded to Sell on Technical Improvements and Mixed Fundamentals

2026-02-26 08:06:20

Makers Laboratories Ltd has seen its investment rating upgraded from Strong Sell to Sell, driven primarily by improved technical indicators and recent positive quarterly financial results. However, the company continues to face challenges in valuation and long-term fundamental strength, prompting a cautious stance despite short-term momentum gains.

Read full news article

Makers Laboratories Ltd Downgraded to Strong Sell Amid Weak Fundamentals and Bearish Technicals

2026-02-18 08:11:39

Makers Laboratories Ltd has been downgraded from a Sell to a Strong Sell rating as of 17 Feb 2026, reflecting a deterioration in its technical outlook, valuation metrics, and long-term financial trends. Despite some positive quarterly results, the company’s overall fundamentals and market performance have raised concerns, prompting a reassessment of its investment appeal within the Pharmaceuticals & Biotechnology sector.

Read full news article

Makers Laboratories Gains 5.85%: 3 Key Factors Driving the Weekly Move

2026-02-14 14:04:33

Key Events This Week

09 Feb: Stock surges 6.58% on strong volume

10 Feb: Q3 FY26 results reveal profit surge

11 Feb: Mixed annual performance reported; stock dips 5.93%

12 Feb: Technical and financial trends improve; stock rallies 7.60%

13 Feb: MarketsMOJO upgrades rating to Sell; stock closes at ₹136.70

Week Open

Rs.129.15

Read full news article

Makers Laboratories Ltd Upgraded to Sell on Improving Financial and Technical Trends

2026-02-13 08:11:15

Makers Laboratories Ltd has seen its investment rating upgraded from Strong Sell to Sell following a marked improvement in its financial performance and technical indicators. Despite lingering concerns over long-term fundamentals and valuation, the recent quarterly results and market momentum have prompted a reassessment of the company’s outlook.

Read full news article

Makers Laboratories Ltd Reports Strong Quarterly Upswing Amid Mixed Annual Performance

2026-02-11 08:00:39

Makers Laboratories Ltd has demonstrated a notable turnaround in its quarterly financial performance for December 2025, registering its highest-ever net sales and profitability metrics despite a challenging nine-month period marked by significant profit contraction. The company’s recent financial trend has shifted from flat to positive, signalling potential recovery in the Pharmaceuticals & Biotechnology sector.

Read full news article

Are Makers Laboratories Ltd latest results good or bad?

2026-02-10 19:27:25

Makers Laboratories Ltd's latest financial results for Q3 FY26 present a mixed picture of operational performance. The company reported consolidated net sales of ₹35.67 crores, reflecting a year-on-year growth of 28.82%, which marks the highest quarterly revenue in at least seven quarters. This growth indicates a positive trend in demand for the company's products. Additionally, the operating margin, excluding other income, improved to 11.66%, showcasing operational leverage and cost management. However, the consolidated net profit for the quarter was ₹0.94 crores, which, while positive compared to the previous quarter's loss, represents a significant decline in profitability when viewed over a nine-month period, with profits plummeting 84.86% year-on-year. This raises concerns about the sustainability of the recent quarterly improvement. On a standalone basis, the company reported a net profit of ₹2.27 ...

Read full news article

Makers Laboratories Q3 FY26: Profit Surge Masks Deeper Structural Concerns

2026-02-10 15:46:52

Makers Laboratories Ltd., a micro-cap pharmaceutical manufacturer with a market capitalisation of ₹85.56 crores, reported a consolidated net profit of ₹0.94 crores for Q3 FY26 (October-December 2025), marking a dramatic turnaround from a loss of ₹0.30 crores in the year-ago quarter. However, the seemingly impressive quarterly performance conceals troubling underlying trends that raise serious questions about the sustainability of this recovery.